Given the fact that decreased levels of NT-proBNP associate with increased body mass and accumulated visceral and liver fat, however, such protective actions of NT-proBNP on adipose tissue may be attenuated in subjects with obesity and MetS, possibly leading to systemic metabolic disturbance. Here, NPPB is linked to obesity disorder.